1 Two Ebola treatments prove effective in DRC outbreak
A study of four Ebola therapeutics demonstrated that two drugs showed significantly improved survival rates, leading to the trial being halted early.
Browsing: Emerging Disease
0 One year into the DRC Ebola outbreak – is there an end in sight?
The outbreak of Ebola in the Democratic Republic of Congo has seen over 2612 cases and 1756 mortalities since it was first announced by the WHO on 1 August 2018. One year on we ask, what have the major milestones been of this outbreak? And where are we now; is there an end in sight?
0 Ebola outbreak declared a Public Health Emergency of International Concern
The fourth International Health Regulations Emergency Committee meeting has concluded by declaring a Public Health Emergency of International Concern, following the recent Ebola virus disease outbreak in the Democratic Republic of the Congo.
0 Monkeypox and more, from public trust to preparedness – an interview with Chikwe Ihekweazu
In this interview we speak to Chikwe Ihekweazu, current Director of the Nigeria Centre for Disease Control, about monkeypox, public trust, surveillance and the factors that influence preparedness.
0 Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
0 Cases of Ebola confirmed in Uganda
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
0 Emerging technologies to investigate coronavirus emergence – an interview with Vineet Menachery
In this interview we speak to Vineet Menachery about his recent talk at the Microbiology Society’s Annual Conference (8–11 April, Belfast, UK) suggesting that CoV emergence is more complicated than receptor binding alone.
0 ECCMID19: Immune response to Ebola 2 years post-infection could provide clues for vaccine development
Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
0 Bombali ebolavirus discovered in bats in Kenya
A recently discovered species of the ebolavirus, the Bombali virus, has been identified in bats in Kenya, marking the first time any ebolavirus has been found in wildlife on the east coast of Africa.
0 Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines
Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.
